-
Je něco špatně v tomto záznamu ?
Effect of P-glycoprotein and Cotreatment with Sofosbuvir on the Intestinal Permeation of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Fumarate
M. Huliciak, I. Lhotska, H. Kocova-Vlckova, V. Halodova, T. Dusek, F. Cecka, F. Staud, I. Vokral, L. Cerveny
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
GAUK 364521
Grantová Agentura, Univerzita Karlova
GACR 18-07281Y
Grantová Agentura České Republiky
SVV No. 260 663
Ministerstvo Školství, Mládeže a Tělovýchovy
EFSA-CDN (reg. no.: CZ.02.1.01/0.0/0.0/16_019/0000841) co-funded by ERDF
Ministerstvo Školství, Mládeže a Tělovýchovy
NLK
ProQuest Central
od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2010-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest)
od 1997-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-01-01 do Před 1 rokem
- MeSH
- adenin metabolismus MeSH
- alanin MeSH
- Caco-2 buňky MeSH
- fumaráty MeSH
- HIV infekce * farmakoterapie MeSH
- látky proti HIV * MeSH
- lidé MeSH
- P-glykoprotein MeSH
- P-glykoproteiny MeSH
- sofosbuvir terapeutické užití MeSH
- tenofovir MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
PURPOSE: We aimed to compare the effects of P-glycoprotein (ABCB1) on the intestinal uptake of tenofovir disoproxil fumarate (TDF), tenofovir alafenamide fumarate (TAF), and metabolites, tenofovir isoproxil monoester (TEM) and tenofovir (TFV), and to study the molecular mechanism of drug-drug interaction (DDI) between sofosbuvir (SOF) and TDF/TAF. METHODS: Bidirectional transport experiments in Caco-2 cells and accumulation studies in precision-cut intestinal slices prepared from the ileal segment of rodent (rPCIS) and human (hPCIS) intestines were performed. RESULTS: TDF and TAF were extensively metabolised but TAF exhibited greater stability. ABCB1 significantly reduced the intestinal transepithelial transfer and uptake of the TFV(TDF) and TFV(TAF)-equivalents. However, TDF and TAF were absorbed more efficiently than TFV and TEM. SOF did not inhibit intestinal efflux of TDF and TAF or affect intestinal accumulation of TFV(TDF) and TFV(TAF)-equivalents but did significantly increase the proportion of absorbed TDF. CONCLUSIONS: TDF and TAF likely produce comparable concentrations of TFV-equivalents in the portal vein and the extent of permeation is reduced by the activity of ABCB1. DDI on ABCB1 can thus potentially affect TDF and TAF absorption. SOF does not inhibit ABCB1-mediated transport of TDF and TAF but does stabilise TDF, albeit without affecting the quantity of TFV(TDF)-equivalents crossing the intestinal barrier. Our data thus suggest that reported increases in the TFV plasma concentrations in patients treated with SOF and TDF result either from a DDI between SOF and TDF that does not involve ABCB1 or from a DDI involving another drug used in combination therapy.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24001255
- 003
- CZ-PrNML
- 005
- 20240213094457.0
- 007
- ta
- 008
- 240109s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11095-023-03581-2 $2 doi
- 035 __
- $a (PubMed)37594591
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Huliciak, Martin $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 50005, Hradec Kralove, Czech Republic
- 245 10
- $a Effect of P-glycoprotein and Cotreatment with Sofosbuvir on the Intestinal Permeation of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Fumarate / $c M. Huliciak, I. Lhotska, H. Kocova-Vlckova, V. Halodova, T. Dusek, F. Cecka, F. Staud, I. Vokral, L. Cerveny
- 520 9_
- $a PURPOSE: We aimed to compare the effects of P-glycoprotein (ABCB1) on the intestinal uptake of tenofovir disoproxil fumarate (TDF), tenofovir alafenamide fumarate (TAF), and metabolites, tenofovir isoproxil monoester (TEM) and tenofovir (TFV), and to study the molecular mechanism of drug-drug interaction (DDI) between sofosbuvir (SOF) and TDF/TAF. METHODS: Bidirectional transport experiments in Caco-2 cells and accumulation studies in precision-cut intestinal slices prepared from the ileal segment of rodent (rPCIS) and human (hPCIS) intestines were performed. RESULTS: TDF and TAF were extensively metabolised but TAF exhibited greater stability. ABCB1 significantly reduced the intestinal transepithelial transfer and uptake of the TFV(TDF) and TFV(TAF)-equivalents. However, TDF and TAF were absorbed more efficiently than TFV and TEM. SOF did not inhibit intestinal efflux of TDF and TAF or affect intestinal accumulation of TFV(TDF) and TFV(TAF)-equivalents but did significantly increase the proportion of absorbed TDF. CONCLUSIONS: TDF and TAF likely produce comparable concentrations of TFV-equivalents in the portal vein and the extent of permeation is reduced by the activity of ABCB1. DDI on ABCB1 can thus potentially affect TDF and TAF absorption. SOF does not inhibit ABCB1-mediated transport of TDF and TAF but does stabilise TDF, albeit without affecting the quantity of TFV(TDF)-equivalents crossing the intestinal barrier. Our data thus suggest that reported increases in the TFV plasma concentrations in patients treated with SOF and TDF result either from a DDI between SOF and TDF that does not involve ABCB1 or from a DDI involving another drug used in combination therapy.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a tenofovir $7 D000068698
- 650 _2
- $a sofosbuvir $x terapeutické užití $7 D000069474
- 650 12
- $a látky proti HIV $7 D019380
- 650 _2
- $a P-glykoprotein $7 D020168
- 650 _2
- $a Caco-2 buňky $7 D018938
- 650 12
- $a HIV infekce $x farmakoterapie $7 D015658
- 650 _2
- $a adenin $x metabolismus $7 D000225
- 650 _2
- $a P-glykoproteiny $7 D018435
- 650 _2
- $a fumaráty $7 D005650
- 650 _2
- $a alanin $7 D000409
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Lhotska, Ivona $u Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05, Hradec Kralove, Czech Republic
- 700 1_
- $a Kocova-Vlckova, Hana $u Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05, Hradec Kralove, Czech Republic
- 700 1_
- $a Halodova, Veronika $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 50005, Hradec Kralove, Czech Republic
- 700 1_
- $a Dusek, Tomas $u Department of Surgery, University Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic
- 700 1_
- $a Cecka, Filip $u Department of Surgery, University Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic
- 700 1_
- $a Staud, Frantisek $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 50005, Hradec Kralove, Czech Republic
- 700 1_
- $a Vokral, Ivan $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 50005, Hradec Kralove, Czech Republic
- 700 1_
- $a Cerveny, Lukas $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 50005, Hradec Kralove, Czech Republic. cervenyl@faf.cuni.cz
- 773 0_
- $w MED00003779 $t Pharmaceutical research $x 1573-904X $g Roč. 40, č. 9 (2023), s. 2109-2120
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37594591 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213094454 $b ABA008
- 999 __
- $a ok $b bmc $g 2049709 $s 1210949
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 40 $c 9 $d 2109-2120 $e 20230818 $i 1573-904X $m Pharmaceutical research $n Pharm Res $x MED00003779
- GRA __
- $a GAUK 364521 $p Grantová Agentura, Univerzita Karlova
- GRA __
- $a GACR 18-07281Y $p Grantová Agentura České Republiky
- GRA __
- $a SVV No. 260 663 $p Ministerstvo Školství, Mládeže a Tělovýchovy
- GRA __
- $a EFSA-CDN (reg. no.: CZ.02.1.01/0.0/0.0/16_019/0000841) co-funded by ERDF $p Ministerstvo Školství, Mládeže a Tělovýchovy
- LZP __
- $a Pubmed-20240109